Incidence and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention

Abstrakt

The incidence and timing of sustained ventricular tachycardia or fibrillation (VT/VF) and its impact on outcomes in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) are poorly understood. To evaluate the association of sustained VT/VF and its timing on the outcomes of patients presenting for primary PCI-an aim not prespecified in the APEX AMI trial.

Klíčová slova

• Acute myocardial infarction
• thrombolytic therapy
• tachycardia
• fibrilation
• trial